Xiaohong Li

932 South Lushan Road
Changsha, 410083, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment

A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: June 15, 2026

Effects of ultrasonic rapid processing method on the protein, DNA, and RNA in paraffin-embedded tissues.

Effects of ultrasonic rapid processing method on the protein, DNA, and RNA in paraffin-embedded tissues.

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Published: August 11, 2025

Alectinib treatment for 2 non-small cell lung carcinoma patients carrying different novel ALK fusions.

Alectinib treatment for 2 non-small cell lung carcinoma patients carrying different novel ALK fusions.

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Published: January 09, 2025

Abnormal mitochondrial iron metabolism damages alveolar type II epithelial cells involved in bleomycin-induced pulmonary fibrosis.

Abnormal mitochondrial iron metabolism damages alveolar type II epithelial cells involved in bleomycin-induced pulmonary fibrosis.

Journal: Theranostics

Published: January 09, 2024

A novel senolytic drug for pulmonary fibrosis: BTSA1 targets apoptosis of senescent myofibroblasts by activating BAX.

A novel senolytic drug for pulmonary fibrosis: BTSA1 targets apoptosis of senescent myofibroblasts by activating BAX.

Journal: Aging cell

Published: January 01, 2024

Omentin-1 induces mechanically activated fibroblasts lipogenic differentiation through pkm2/yap/pparγ pathway to promote lung fibrosis resolution.

Omentin-1 induces mechanically activated fibroblasts lipogenic differentiation through pkm2/yap/pparγ pathway to promote lung fibrosis resolution.

Journal: Cellular and molecular life sciences : CMLS

Published: June 22, 2023

Therapeutic Effects of Omentin-1 on Pulmonary Fibrosis by Attenuating Fibroblast Activation via AMP-Activated Protein Kinase Pathway.

Therapeutic Effects of Omentin-1 on Pulmonary Fibrosis by Attenuating Fibroblast Activation via AMP-Activated Protein Kinase Pathway.

Journal: Biomedicines

Published: September 20, 2022

Iron deposition-induced ferroptosis in alveolar type II cells promotes the development of pulmonary fibrosis.

Iron deposition-induced ferroptosis in alveolar type II cells promotes the development of pulmonary fibrosis.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: February 09, 2021

NMDA receptor activation inhibits the protective effect of BM‑MSCs on bleomycin‑induced lung epithelial cell damage by inhibiting ERK signaling and the paracrine factor HGF.

NMDA receptor activation inhibits the protective effect of BM‑MSCs on bleomycin‑induced lung epithelial cell damage by inhibiting ERK signaling and the paracrine factor HGF.

Journal: International journal of molecular medicine

Published: November 14, 2018

Omentin-1 protects against bleomycin-induced acute lung injury.

Omentin-1 protects against bleomycin-induced acute lung injury.

Journal: Molecular immunology

Published: May 06, 2018

NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis.

NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: May 04, 2018

Omentin-A Novel Adipokine in Respiratory Diseases.

Omentin-A Novel Adipokine in Respiratory Diseases.

Journal: International journal of molecular sciences

Published: November 26, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026